Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    1.

    CD28/CD154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector t-cell inhibition and regulatory T-cell expansion.

    Rigby MR, Trexler AM, Pearson TC, Larsen CP.

    Diabetes. 2008 Oct;57(10):2672-83. Epub 2008 May 20.PMID: 18492787 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.
    4.

    Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.

    Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, Anderson CC, Shapiro AM.

    Diabetes. 2006 Jan;55(1):27-33.PMID: 16380473 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.

    Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ.

    Diabetes. 2007 Aug;56(8):2116-23. Epub 2007 May 11.PMID: 17496235 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells.

    Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, Thivolet C.

    Diabetologia. 2009 Jul;52(7):1391-9. Epub 2009 May 7.PMID: 19421731 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.

    Molano RD, Berney T, Li H, Cattan P, Pileggi A, Vizzardelli C, Kenyon NS, Ricordi C, Burkly LC, Inverardi L.

    Diabetes. 2001 Feb;50(2):270-6.PMID: 11272136 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.

    Ha J, Bingaman AW, Durham MM, Pearson TC, Larsen CP.

    Transpl Immunol. 2001 Oct;9(1):13-7.PMID: 11680567 [PubMed - indexed for MEDLINE]Related articles

    9.

    Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

    Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, Bluestone JA.

    J Clin Invest. 2004 Oct;114(7):979-87.PMID: 15467837 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Contribution of regulatory T cells and effector T cell deletion in tolerance induction by costimulation blockade.

    Verbinnen B, Billiau AD, Vermeiren J, Galicia G, Bullens DM, Boon L, Cadot P, Hens G, Dewolf-Peeters C, Van Gool SW, Ceuppens JL.

    J Immunol. 2008 Jul 15;181(2):1034-42.PMID: 18606655 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.

    Wang CJ, Chou FC, Chu CH, Wu JC, Lin SH, Chang DM, Sytwu HK.

    Diabetes. 2008 Jul;57(7):1861-9. Epub 2008 Apr 16.PMID: 18420489 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.

    Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST.

    Diabetes. 2009 Jul;58(7):1568-77. Epub 2009 Mar 31.PMID: 19336675 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

    Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

    Transplantation. 2004 Apr 15;77(7):990-7.PMID: 15087759 [PubMed - indexed for MEDLINE]Related articles

    15.

    Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.

    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.

    J Immunol. 1996 Oct 15;157(8):3737-43.PMID: 8871677 [PubMed - indexed for MEDLINE]Related articles

    16.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    17.

    Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.

    You S, Slehoffer G, Barriot S, Bach JF, Chatenoud L.

    Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14580-5. Epub 2004 Aug 30.PMID: 15340148 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.

    Chen C, Lee WH, Yun P, Snow P, Liu CP.

    J Immunol. 2003 Jul 15;171(2):733-44.PMID: 12847240 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data